Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal determinants of infant immunity to pertussis
2022-002697-80Phase 4Active
- Sponsor
- Université libre de Bruxelles
- Start
- Sep 2022
- Countries
- 1
01
Overview
Phase 4 trial of diphtheria, tetanus, and acellular pertussis vaccine in pertussis (2 arms), sponsored by Université libre de Bruxelles. Primary endpoint: Magnitude and quality of adaptive immune responses to Tdap immunization. Started Sep 2022; status: active.
02
Drugs
diphtheria, tetanus, and acellular pertussis vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on 2022-002697-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002697-80.